SCHEMBL23977348

SCHEMBL23977348

C#Cc1ccc(Cn2cnc3c(N)ncnc32)c(OC)c1

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NSD3 Q9BZ95 2/20 0.50
ADORA2A P29274 3/20 0.47
PI4KA P42356 3/20 0.47
PI4K2B Q8TCG2 3/20 0.47
PI4K2A Q9BTU6 3/20 0.47
PI4KB Q9UBF8 3/20 0.47
PIK3CD O00329 8/20 0.47
ADORA1 P30542 2/20 0.46
LMNA P02545 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
HPGD P15428 1/20 0.46
NSD2 O96028 1/20 0.46
ADORA2B P29275 1/20 0.44
HSP90AA1 P07900 1/20 0.43
HSP90AB1 P08238 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30225305 0.83 ADORA2A (0.50) NSD3ADORA2API4KAPI4K2BPI4K2A
SCHEMBL23977279 0.83 ADORA2A (0.50) NSD3ADORA2API4KAPI4K2BPI4K2A
SCHEMBL30225385 0.78 ADORA2A (0.68) NSD3ADORA2API4KAPI4K2BPI4K2A
SCHEMBL23977384 0.78 ADORA2A (0.68) NSD3ADORA2API4KAPI4K2BPI4K2A
SCHEMBL30291143 0.76 NSD2 (0.47) NSD3ADORA2API4KAPI4K2BPI4K2A
SCHEMBL23977338 0.76 ADORA2A (0.54) NSD3ADORA2API4KAPI4K2BPI4K2A
SCHEMBL30225408 0.76 ADORA2A (0.54) NSD3ADORA2API4KAPI4K2BPI4K2A
SCHEMBL11862441 0.75 ADORA2A (0.60) NSD3ADORA2API4KAPI4K2BPI4K2A
SCHEMBL3395858 0.73 HSP90AA1 (0.62) NSD3ADORA2API4KAPI4K2BPI4K2A
SCHEMBL13268696 0.72 ADORA2A (0.56) NSD3ADORA2API4KAPI4K2BPI4K2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219964-A1 ANTIBACTERIAL AND ANTIFUNGAL PLEUROMUTILIN CONJUGATES SYDDANSK UNIVERSITET (DK) 2023-07-13 US disclosed
US-20230219964-A1 ANTIBACTERIAL AND ANTIFUNGAL PLEUROMUTILIN CONJUGATES SYDDANSK UNIVERSITET (DK) 2023-07-13 US disclosed
US-20230219964-A1 ANTIBACTERIAL AND ANTIFUNGAL PLEUROMUTILIN CONJUGATES SYDDANSK UNIVERSITET (DK) 2023-07-13 US disclosed
EP-4143172-A1 ANTIBACTERIAL AND ANTIFUNGAL PLEUROMUTILIN CONJUGATES Syddansk Universitet (DK) 2023-03-08 EP disclosed
CN-115720579-A Antibacterial and antifungal pleuromutilin conjugates 赛丹思科大学 2023-02-28 CN disclosed
WO-2021219813-A1 ANTIBACTERIAL AND ANTIFUNGAL PLEUROMUTILIN CONJUGATES SYDDANSK UNIVERSITET (DK) 2021-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219964-A1 ANTIBACTERIAL AND ANTIFUNGAL PLEUROMUTILIN CONJUGATES HDAC6, Q6ZSR9, MON2 NSD3 4174/4885ADORA2A 4156/4885PI4KA 1564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.